DAIWA PHARMACEUTICAL CO LTD has a total of 21 patent applications. Its first patent ever was published in 1995. It filed its patents most often in Taiwan, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and macromolecular chemistry and polymers are OPOCRIN SPA, BIOCYDEX and LTD LIABILITY COMPANY NEARMEDIC PLUS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Taiwan | 4 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | China | 2 | |
#6 | Hong Kong | 2 | |
#7 | Brazil | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Machines | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Polysaccharides | |
#5 | Unspecified technologies | |
#6 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Maeda Hiroaki | 10 |
#2 | Igari Naoki | 7 |
#3 | Zhu Xia | 7 |
#4 | Omura Kazunobu | 5 |
#5 | Hitosugi Masahito | 5 |
#6 | Ghoneum Mamdooh H | 3 |
#7 | Ninomiya Yasuo | 3 |
#8 | Kazunobu Omura | 1 |
#9 | Hiroaki Maeda | 1 |
#10 | Mamdooh Ghoneum H | 1 |
Publication | Filing date | Title |
---|---|---|
TW202031143A | Frailty improving method and frailty improving food employing polysaccharide complex as effective ingredient for frailty improvement | |
WO2020166063A1 | Method for improving frailty and food for improving frailty | |
HK1253292A1 | Angiogenesis inhibitor | |
US2018325976A1 | Angiogenesis inhibitor | |
EP1657304A1 | Blood-viscosity reducing agent | |
WO2006082647A1 | Immunopotentiator | |
US5560914A | Immunopotentiator and method of manufacturing the same |